On the recordMarch 12, 2014
I believe there should be an avenue for patients to inform the FDA of their opinions about what might be considered for breakthrough.
Source
congress.govI believe there should be an avenue for patients to inform the FDA of their opinions about what might be considered for breakthrough.
Bennet advocates for patient input in the FDA's breakthrough therapy process.
Share
More from Michael Bennet
I think it’s a tragedy that companies are leaving Colorado, and it’s one of the reasons why I’m running for governor.
This is not a podcast. It is the American people's health that is on the line here.
I will continue to push for necessary guardrails, critical reforms, and work towards preventing the opening of this facility.
We have had our disagreements. That's obvious to anybody who's been watching this race, and ... and no doubt we will have healthy disagreements in the future — but we agree on what the problems are.